Anne‐Claire Toffart

Integrative and comparative genomic analyses identify clinically relevant pulmonary carcinoid groups and unveil the supra-carcinoids

Nicolas Alcala, Noémie Leblay, Alice‐Agnes Gabriel et al. · Nature Communications · 2019 · 214 citations · Full text

Medicine, Immunology, Oncology +17

Circulating free DNA concentration is an independent prognostic biomarker in lung cancer

Claire Tissot, Anne‐Claire Toffart, Stéphanie Villar et al. · European Respiratory Journal · 2015 · 150 citations · Full text

Medicine, Molecular Medicine, Oncology +16

Efficacy of Immune Checkpoint Inhibitors in Lung Sarcomatoid Carcinoma

Charlotte Domblides, Karen Leroy, I. Monnet et al. · Journal of Thoracic Oncology · 2020 · 136 citations · Full text

Life Sciences, Immunology, Oncology +14

Circulating tumour cells as a potential biomarker for lung cancer screening: a prospective cohort study

Charles‐Hugo Marquette, Jacques Boutros, Jonathan Benzaquen et al. · The Lancet Respiratory Medicine · 2020 · 136 citations · Full text

Medicine, Oncology, Cancer Screening +16

Use of Intensive Care in Patients With Nonresectable Lung Cancer

Anne‐Claire Toffart, Clémence Minet, Bruno Raynard et al. · CHEST Journal · 2010 · 95 citations

Medicine, Oncology, Surgery +14